Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-13T20:08:33.142Z Has data issue: false hasContentIssue false

Editorial: Neuroscience-based Nomenclature (NbN) Replaces the Current Label of Psychotropic Medications in European Psychiatry

Published online by Cambridge University Press:  30 December 2016

P. Gorwood*
Affiliation:
CMME, Hôpital Sainte-Anne, Paris-Descartes University, Inserm 894, 75014Paris, France
S. Frangou
Affiliation:
Icahn School of Medicine at Mount Sinai 1425, Madison AvenueNew York, NY10029, USA
R. Heun
Affiliation:
Radbourne Unit, Royal Derby Hospital Uttoexter Road, DerbyDE 223WQ, UK
*
* Corresponding author at: Sainte-Anne hospital, Inserm, CMME, 100, rue de la Santé, 75014 Paris, France. Tel.: + 33 1 45 65 86 39 E-mail address:P.gorwood@ch-sainte-anne.fr (P. Gorwood)
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Copyright
Copyright © Elsevier Masson SAS 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Zohar, J.Nutt, D.J.Kupfer, D.J.Moller, H.J.Yamawaki, S.Spedding, M.et al.A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol 2014; 24: 10051014CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.